GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » FCF Yield %

Laurus Labs (BOM:540222) FCF Yield % : -0.05 (As of May. 30, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Laurus Labs's Trailing 12-Month Free Cash Flow is ₹-126 Mil, and Market Cap is ₹237,311 Mil. Therefore, Laurus Labs's FCF Yield % for today is -0.05%.

The historical rank and industry rank for Laurus Labs's FCF Yield % or its related term are showing as below:

BOM:540222' s FCF Yield % Range Over the Past 10 Years
Min: -0.05   Med: 0   Max: 0.02
Current: -0.05


During the past 11 years, the highest FCF Yield % of Laurus Labs was 0.02%. The lowest was -0.05%. And the median was 0.00%.

BOM:540222's FCF Yield % is ranked better than
51.48% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.31 vs BOM:540222: -0.05

Laurus Labs's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


Laurus Labs FCF Yield % Historical Data

The historical data trend for Laurus Labs's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs FCF Yield % Chart

Laurus Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.63 0.23 0.11 0.02 -0.06

Laurus Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Laurus Labs's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laurus Labs's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Laurus Labs's FCF Yield % falls into.



Laurus Labs FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Laurus Labs's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-126.2 / 211139.9305
=-0.06%

Laurus Labs's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 211139.9305
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laurus Labs FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Laurus Labs FCF Yield % Related Terms

Thank you for viewing the detailed overview of Laurus Labs's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs (BOM:540222) Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines